Insider Shareholders with Direct Ownership of Inovio Pharmaceuticals, Inc. (INO)
This section provides a comprehensive overview of the insiders with direct ownership of Inovio Pharmaceuticals, Inc. (INO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
INOVIO PHARMACEUTICALS, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Jong Joseph Kim
Chief Executive Officer |
657,541 | 423,227 | 1,422,627 $2.63 Million | 16 |
Mar 11, 2022
Reduced 2.71%
|
David B. Weiner
Director |
207,657 | 100,670 | 82,509 $152,641 | 27 |
May 15, 2024
Added 2.56%
|
Jacqueline Elizabeth Shea
Chief Executive Officer |
524,843 | 321,512 | 33,647 $62,246 | 31 |
May 15, 2024
Reduced 18.66%
|
Peter Kies
CFO |
417,162 | 294,835 | 24,367 $45,078 | 28 |
May 15, 2024
Reduced 9.51%
|
Laurent Humeau
Chief Scientific Officer |
408,175 | 191,974 | 24,337 $45,023 | 23 |
May 15, 2024
Reduced 6.54%
|
Simon X Benito
Director |
62,616 | 17,795 | 10,024 $18,544 | 19 |
May 15, 2024
Added 17.77%
|
Wendy L Yarno
Director |
51,956 | 0 | 8,345 $15,438 | 5 |
May 15, 2024
Added 20.61%
|
Michael John Sumner
Chief Medical Officer |
40,303 | 0 | 8,219 $15,205 | 3 |
Jun 30, 2024
Added 26.19%
|
Ann Calby Miller
Director |
56,413 | 0 | 7,710 $14,263 | 6 |
May 15, 2024
Added 21.93%
|
Jay Shepard
Director |
60,687 | 0 | 7,042 $13,027 | 7 |
May 15, 2024
Added 23.52%
|
Roger D Dansey
Director |
46,166 | 0 | 6,749 $12,485 | 5 |
May 15, 2024
Added 24.3%
|
Lota S. Zoth
Director |
56,046 | 13,267 | 6,559 $12,134 | 11 |
May 15, 2024
Added 24.83%
|